Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Z Gastroenterol

Retrieve available abstracts of 24 articles:
HTML format

Single Articles

    July 2021
  1. CORNBERG M, Sandmann L, Protzer U, Niederau C, et al

    Z Gastroenterol. 2021;59:691-776.

  2. SANDMANN L, Petersen J, Cornberg M

    Z Gastroenterol. 2021;59:641-643.

  3. JANSEN PL, van Leeuwen P, Sandmann L, Cornberg M, et al

    Z Gastroenterol. 2021;59:e80-e90.

    June 2021
  4. SCURT FG, Bose K, Canbay A, Mertens PR, et al
    [Chronic kidney injury in patients with liver diseases - Reappraising pathophysiology and treatment options].
    Z Gastroenterol. 2021;59:560-579.
    PubMed     Abstract available

    March 2021
  5. SIMON KG, Serfert Y, Buggisch P, Mauss S, et al
    [Evolution of hepatitis C virus genotype 1a vs. 1b distribution in Germany between 2004 and 2018 - An analysis of 17093 patients from different real world registries].
    Z Gastroenterol. 2021;59:241-249.
    PubMed     Abstract available

    November 2020
  6. HUPPE D, Niederau C, Serfert Y, Hartmann H, et al
    [Problems in treating patients with chronic HCV infection due to the COVID-19 pandemic and during the lockdown phase in Germany].
    Z Gastroenterol. 2020 Nov 9. doi: 10.1055/a-1291-8518.
    PubMed     Abstract available

  7. SARRAZIN C, Zimmermann T, Berg T, Hinrichsen H, et al

    Z Gastroenterol. 2020;58:1110-1131.

  8. SARRAZIN C, Zimmermann T, Zeuzem S

    Z Gastroenterol. 2020;58:1107-1108.

    September 2020
  9. VERMEHREN J, Serfert Y, Cornberg M, Stoehr A, et al
    Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R).
    Z Gastroenterol. 2020;58:841-846.
    PubMed     Abstract available

    May 2020
  10. BERNHARD B, Stickel F
    Successful fourth line treatment of a relapse patient with chronic hepatitis C virus infection genotype 3a using sofosbuvir, glecaprevir/pibrentasvir, and ribavirin: a case report.
    Z Gastroenterol. 2020;58:451-455.
    PubMed     Abstract available

  11. SEBODE M, Kloppenburg A, Aigner A, Lohse AW, et al
    Population-based study of autoimmune hepatitis and primary biliary cholangitis in Germany: rising prevalences based on ICD codes, yet deficits in medical treatment.
    Z Gastroenterol. 2020;58:431-438.
    PubMed     Abstract available

    February 2020
  12. SCHMITT A, Gunther R, Mauss S, Boeker KHW, et al
    Treatment-failure to direct antiviral HCV regimens in real world: frequency, patient characteristics and rescue therapy - data from the German hepatitis C registry (DHC-R).
    Z Gastroenterol. 2020 Feb 10. doi: 10.1055/a-1068-3056.
    PubMed     Abstract available

  13. SCHOCHOW M, Steger F
    Medical care or clinical research on humans? Contaminated anti-D immunoglobulin in the GDR and its consequences.
    Z Gastroenterol. 2020;58:127-132.
    PubMed     Abstract available

    May 2019
  14. SARRAZIN C, Buggisch P, Mauss S, Muller T, et al
    Evolution of HCV patient characteristics and DAA regimens in the German Hepatitis C Registry (DHC-R) in 2014 and 2015.
    Z Gastroenterol. 2019;57:584-592.
    PubMed     Abstract available

    February 2019
  15. MAUSS S, Buendgens L, Christensen S, Ingiliz P, et al
    Risk factors for remaining liver injury in patients with virological elimination of chronic hepatitis C.
    Z Gastroenterol. 2019;57:139-147.
    PubMed     Abstract available

    January 2019
  16. BARTENSCHLAGER R, Urban S, Protzer U
    Towards curative therapy of chronic viral hepatitis.
    Z Gastroenterol. 2019;57:61-73.
    PubMed     Abstract available

  17. HUPPE D, Serfert Y, Buggisch P, Mauss S, et al
    [4 years of direct-acting antivirals (DAAs) in the German Hepatitis C-Registry (DHC-R)].
    Z Gastroenterol. 2019;57:27-36.
    PubMed     Abstract available

  18. BENGSCH B, Thimme R
    Success of immune checkpoint blockade therapies - mechanisms and implications for hepatology.
    Z Gastroenterol. 2019;57:74-86.
    PubMed     Abstract available

    June 2018
  19. SARRAZIN C, Zimmermann T, Berg T, Neumann UP, et al
    [Prophylaxis, diagnosis and therapy of hepatitis-C-virus (HCV) infection: the German guidelines on the management of HCV infection - AWMF-Register-No.: 021/012].
    Z Gastroenterol. 2018 Jun 26. doi: 10.1055/a-0599-1320.

    January 2018
  20. HUESING-KABAR A, Dohna CZ, Heinzow H, Cicinnati VR, et al
    Risk factors for allograft failure in liver transplant recipients.
    Z Gastroenterol. 2018 Jan 16. doi: 10.1055/s-0043-125225.
    PubMed     Abstract available

  21. WEILER-NORMANN C, Hartl J, Weidemann S, von Pein UM, et al
    Acute hepatitis as a prequel to very severe aplastic anemia.
    Z Gastroenterol. 2018;56:51-54.
    PubMed     Abstract available

  22. WEHMEYER MH, Hartl J, von Wulffen M, Lohse AW, et al
    Time trend of reported cases and publications: hepatitis E in comparison to hepatitis A - D in Germany from 2001 to 2016.
    Z Gastroenterol. 2018;56:29-35.
    PubMed     Abstract available

    November 2017
  23. GROSS MJ, Harter G, Backhus J, Zizer E, et al
    Direct-acting antiviral agents in the treatment of chronic Hepatitis C - "Real-life" experience from an academic centre and two specialized clinical practices.
    Z Gastroenterol. 2017 Nov 7. doi: 10.1055/s-0043-121892.
    PubMed     Abstract available

    September 2017
  24. SCHLEVOGT B, Deterding K, Port K, Siederdissen CHZ, et al
    Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-up.
    Z Gastroenterol. 2017;55:848-856.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.